Wednesday, April 24, 2013

Do you know the regulatory pathways for successful clinical trial and marketing applications in China?

Understanding and Navigating the Regulatory System in China
June 23 from 9:00AM – 5:00PM in Boston


This tutorial will provide an overview of the regulatory system in China, including the agencies and institutions at the central government and provincial levels, as well as their roles and responsibilities. Various regulations for product registration, clinical trials, and safety reporting will be presented, and the regulatory pathways and strategic considerations for clinical trial and marketing applications will be discussed. A step-by-step roadmap of how to navigate the regulatory system in China for clinical trial approval and product registration will also be discussed. This discussion will include key points to consider, strategies, and tactics.


Instructor(s):
Laurence Bin Huang, MS
Executive Director, Regulatory Affairs
AstraZeneca Pharmaceutical Co., Ltd., China

Wendy Yan, PharmD
Global Regulatory Strategist
Bayer Healthcare Co. Ltd, China


What’s more…Receive $100 off of your DIA 2013 Annual Meeting registration by registering for two half day tutorials or one full day tutorial. Please note purchases must be made at the same time in order to receive the discount.


Visit www.diahome.org/DIA2013 for more details on the DIA 2013 Annual Meeting being held June 23-27 in Boston, MA.

Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.

No comments:

Post a Comment